BioCryst Pharmaceuticals
BCRX
#4939
Rank
C$2.74 B
Marketcap
C$10.65
Share price
-2.10%
Change (1 day)
8.11%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2026 (TTM): C-$1.89

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$1.93. In 2025 the company made an earnings per share (EPS) of C$1.79 an increase over its 2024 EPS that were of C-$0.61.

EPS history for BioCryst Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.89-205.56%
2025C$1.79-390.7%
2024C-$0.61-63.56%
2023C-$1.69-11.28%
2022C-$1.9029.13%
2021C-$1.47-4.63%
2020C-$1.5410.2%
2019C-$1.400%
2018C-$1.4025.64%
2017C-$1.124%
2016C-$1.0727.12%
2015C-$0.84-13.24%
2014C-$0.9723.64%
2013C-$0.79-30.38%
2012C-$1.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
C-$4.43 129.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.11-313.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C-$3.76 94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C-$0.29-85.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C-$2.17 12.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.22 222.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C-$0.63-67.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$4.55 135.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$7.21 273.33%๐Ÿ‡บ๐Ÿ‡ธ USA